{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:30:12Z","timestamp":1784619012238,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1392-8","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T01:03:25Z","timestamp":1566522205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-1034","authenticated-orcid":false,"given":"Paul M.","family":"McKeigue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Spiliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McGurnaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Blackbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Onengut-Gomuscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin N.","family":"A. Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"J. Strachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Thekkepat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"MacRury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Colhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2337\/diab.27.1.S262","volume":"27 Suppl 1","author":"S Madsbad","year":"1978","unstructured":"Madsbad S, Faber OK, Binder C, McNair P, Christiansen C, Transb\u00f8l I. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes. 1978; 27 Suppl 1:262\u20134.","journal-title":"Diabetes"},{"key":"1392_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","volume":"57","author":"RA Oram","year":"2014","unstructured":"Oram RA, Jones AG, Besser REJ, Knight BA, Shields BM, Brown RJ, et al.The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia. 2014; 57:187\u201391.","journal-title":"Diabetologia"},{"key":"1392_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, et al.Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care. 2015; 38:476\u201381.","journal-title":"Diabetes Care"},{"key":"1392_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/1753-0407.12376","volume":"8","author":"X Li","year":"2016","unstructured":"Li X, Cheng J, Zhou Z. Revisiting multiple models of progression of beta-cell loss of function in type 1 diabetes: significance for prevention and cure. J Diabetes. 2016; 8:460\u20139.","journal-title":"J Diabetes"},{"key":"1392_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/dom.12216","volume":"16","author":"A Barker","year":"2014","unstructured":"Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, et al.Age-dependent decline of \u03b2-cell function in type 1 diabetes after diagnosis: A multi-centre longitudinal study. Diabetes Obes Metab. 2014; 16:262\u20137.","journal-title":"Diabetes Obes Metab"},{"key":"1392_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00125-018-4555-9","volume":"61","author":"D Roshandel","year":"2018","unstructured":"Roshandel D, Gubitosi-Klug R, Bull SB, Canty AJ, Pezzolesi MG, King GL, et al.Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes. Diabetologia. 2018; 61:1098\u2013111.","journal-title":"Diabetologia"},{"key":"1392_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al.Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015; 313:37\u201344.","journal-title":"JAMA"},{"key":"1392_CR8","first-page":"796","volume":"46","author":"T Akbar","year":"2017","unstructured":"Akbar T, McGurnaghan S, Palmer CNA, Livingstone SJ, Petrie J, Chalmers J, et al. Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO). Int J Epidemiol. 2017; 46:796\u2013796i.","journal-title":"Int J Epidemiol"},{"key":"1392_CR9","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/dme.13142","volume":"33","author":"SV Hope","year":"2016","unstructured":"Hope SV, Knight BA, Shields BM, Hattersley AT, McDonald TJ, Jones AG. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. Diabet Med. 2016; 33:1554\u20138.","journal-title":"Diabet Med"},{"key":"1392_CR10","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1373\/clinchem.2009.129312","volume":"55","author":"TJ McDonald","year":"2009","unstructured":"McDonald TJ, Knight BA, Shields BM, Bowman P, Salzmann MB, Hattersley AT. Stability and reproducibility of a single-sample urinary C-peptide\/creatinine ratio and its correlation with 24-h urinary C-peptide. Clin Chem. 2009; 55:2035\u20139.","journal-title":"Clin Chem"},{"key":"1392_CR11","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.2337\/dc11-1161","volume":"34","author":"M Schlosser","year":"2011","unstructured":"Schlosser M, Mueller PW, Achenbach P, Lampasona V, Bingley PJ. Participating Laboratories. Diabetes Antibody Standardization Program: first evaluation of assays for autoantibodies to IA-2 \u03b2. Diabetes Care. 2011; 34:2410\u20132.","journal-title":"Diabetes Care"},{"key":"1392_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ng.3571","volume":"48","author":"P-R Loh","year":"2016","unstructured":"Loh P-R, Palamara PF, Price AL. Fast and accurate long-range phasing in a UK Biobank cohort. Nat Genet. 2016; 48:811\u20136.","journal-title":"Nat Genet"},{"key":"1392_CR13","doi-asserted-by":"crossref","unstructured":"Spiliopoulou A, Colombo M, Plant D, Nair N, Cui J, Coenen MJ, et al.Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. Annals Rheum Dis. 2019.","DOI":"10.1136\/annrheumdis-2018-214877"},{"issue":"6","key":"1392_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"Jeffrey C Barrett","year":"2009","unstructured":"Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al.Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41:703\u20137.","journal-title":"Nature Genetics"},{"key":"1392_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris AP, Voight BF, Teslovich TM, Ferreira T, Segr\u00e8 AV, Steinthorsdottir V, et al.Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44:981\u201390.","journal-title":"Nat Genet"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu S, Chen W-M, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, et al.Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015; 47:381\u20136.","journal-title":"Nat Genet"},{"key":"1392_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/tpj.2013.18","volume":"14","author":"X Zheng","year":"2014","unstructured":"Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, et al.HIBAG \u2013 HLA genotype imputation with attribute bagging. Pharmacogenomics J. 2014; 14:192\u2013200.","journal-title":"Pharmacogenomics J"},{"key":"1392_CR18","doi-asserted-by":"crossref","unstructured":"Gourraud P-A, Khankhanian P, Cereb N, Yang SY, Feolo M, Maiers M, et al.HLA Diversity in the 1000 Genomes Dataset. PLoS ONE. 2014:9.","DOI":"10.1371\/journal.pone.0097282"},{"key":"1392_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/dc15-1111","volume":"39","author":"RA Oram","year":"2016","unstructured":"Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, et al.A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care. 2016; 39:337\u201344.","journal-title":"Diabetes Care"},{"key":"1392_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ajhg.2016.02.012","volume":"98","author":"H Chen","year":"2016","unstructured":"Chen H, Wang C, Conomos MP, Stilp AM, Li Z, Sofer T, et al.Control for population structure and relatedness for binary traits in genetic association studies via logistic mixed models. Am J Human Genet. 2016; 98:653\u201366.","journal-title":"Am J Human Genet"},{"key":"1392_CR21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/dme.12850","volume":"32","author":"WM Kuhtreiber","year":"2015","unstructured":"Kuhtreiber WM, Washer SLL, Hsu E, Zhao M, Reinhold P, Burger D, et al.Low levels of C-peptide have clinical significance for established type 1 diabetes. Diabet Med A J B Diabet Assoc. 2015; 32:1346\u201353.","journal-title":"Diabet Med A J B Diabet Assoc"},{"key":"1392_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2337\/dc07-1158","volume":"31","author":"A Petrone","year":"2008","unstructured":"Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, et al.The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care. 2008; 31:1214\u20138.","journal-title":"Diabetes Care"},{"key":"1392_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00125-017-4440-y","volume":"61","author":"JRJ Inshaw","year":"2017","unstructured":"Inshaw JRJ, Walker NM, Wallace C, Bottolo L, Todd JA. The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age. Diabetologia. 2017; 61:147\u201357.","journal-title":"Diabetologia"},{"key":"1392_CR24","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.2337\/dc18-1032","volume":"41","author":"DL Cousminer","year":"2018","unstructured":"Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A, Hawa MI, et al.First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes. Diabetes Care. 2018; 41:2396\u2013403.","journal-title":"Diabetes Care"},{"key":"1392_CR25","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.1073\/pnas.1402571111","volume":"111","author":"T Fl\u00f8yel","year":"2014","unstructured":"Fl\u00f8yel T, Brorsson C, Nielsen LB, Miani M, Bang-Berthelsen CH, Friedrichsen M, et al.CTSH regulates \u03b2-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A. 2014; 111:10305\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1392_CR26","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.2337\/db13-0227","volume":"62","author":"LM \u2019t Hart","year":"2013","unstructured":"\u2019t Hart LM, Fritsche A, Nijpels G, van Leeuwen N, Donnelly LA, Dekker JM, et al.The CTRB1\/2 locus affects diabetes susceptibility and treatment via the incretin pathway. Diabetes. 2013; 62:3275\u201381.","journal-title":"Diabetes"},{"key":"1392_CR27","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2337\/dc18-0465","volume":"41","author":"BM Shields","year":"2018","unstructured":"Shields BM, McDonald TJ, Oram R, Hill A, Hudson M, Leete P, et al.C-Peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase. Diabetes Care. 2018; 41:1486\u201392.","journal-title":"Diabetes Care"},{"key":"1392_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1464-5491.1994.tb00275.x","volume":"11","author":"PZ Zimmet","year":"1994","unstructured":"Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al.Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med. 1994; 11:299\u2013303.","journal-title":"Diabet Med"},{"key":"1392_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tem.2018.07.001","volume":"29","author":"R Mishra","year":"2018","unstructured":"Mishra R, Hodge KM, Cousminer DL, Leslie RD, Grant SFA. A global perspective of latent autoimmune diabetes in adults. Trends Endocrinol Metab. 2018; 29:638\u201350.","journal-title":"Trends Endocrinol Metab"},{"key":"1392_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/diab.35.2.237","volume":"35","author":"LC Groop","year":"1986","unstructured":"Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes. 1986; 35:237\u201341.","journal-title":"Diabetes"},{"key":"1392_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/1047-2797(93)90004-N","volume":"3","author":"MJ Prior","year":"1993","unstructured":"Prior MJ, Prout T, Miller D, Ewart R, Kumar D. C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. The ETDRS Research Group. Annals Epidemiol. 1993; 3:9\u201317.","journal-title":"Annals Epidemiol"},{"key":"1392_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/dmrr.877","volume":"24","author":"RDG Leslie","year":"2008","unstructured":"Leslie RDG, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, et al.Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev. 2008; 24:511\u20139.","journal-title":"Diabetes Metab Res Rev"},{"key":"1392_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","volume":"383","author":"T Tuomi","year":"2014","unstructured":"Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet (London, England). 2014; 383:1084\u201394.","journal-title":"Lancet (London, England)"},{"key":"1392_CR34","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.2337\/dc12-2328","volume":"36","author":"BM Brooks-Worrell","year":"2013","unstructured":"Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, et al.Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes. Diabetes Care. 2013; 36:4098\u2013103.","journal-title":"Diabetes Care"},{"key":"1392_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12916-017-0846-0","volume":"15","author":"R Mishra","year":"2017","unstructured":"Mishra R, Chesi A, Cousminer DL, Hawa MI, Bradfield JP, Hodge KM, et al.Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Med. 2017; 15:88.","journal-title":"BMC Med"},{"key":"1392_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018; 6:122\u20139.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1392-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T23:11:20Z","timestamp":1598051480000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1392-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1392-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with the ethical principles in the Declaration of Helsinki and was approved by the Tayside Research Ethics Committee (reference 10\/S1402\/43). Informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HC receives research support and honoraria and is a member of advisory panels or speaker\u2019s bureaus for Sanofi Aventis, Regeneron, Novartis, Novo-Nordisk and Eli Lilly. HC receives or has recently received non-binding research support from Pfizer, AstraZeneca and Novo-Nordisk. HC holds shares in Roche and Bayer. RL receives personal fees and non-financial support from Novo Nordisk, personal fees from Eli Lilly Ltd and non-financial support from Merck Sharp and Dohme. JP receives personal fees from Novo Nordisk, non-financial support from Merck (Germany) and Itamar Medical, personal fees from Lilly, ACI Clinical, Pfizer, Astra Zeneca and grants from Janssen. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}